South Africa had become a global leader in medical research, particularly in HIV and tuberculosis, thanks to years of investment and collaboration. But recent funding cuts by the Trump administration—slashing hundreds of millions in U.S. support—have gutted critical programs, leaving labs shuttered, jobs lost, and groundbreaking research in jeopardy. Experts warn the damage could take decades to undo.

Editor’s Note: This isn’t just a blow to South Africa—it’s a setback for global health. The country was a linchpin in fighting diseases that affect millions worldwide, and these cuts ripple far beyond its borders. It’s a stark reminder of how political decisions can dismantle years of progress overnight, with real consequences for people’s lives.

Health experts are sounding the alarm about how Trump's travel restrictions—targeting 19 countries—could throw a wrench into global health collaboration. The ban might block researchers, doctors, and public health workers from sharing critical knowledge, slowing down responses to outbreaks and stifling medical progress. It’s not just about politics; it’s about whether life-saving science gets stuck at the border.

Editor’s Note: When scientists can’t cross borders easily, neither can breakthroughs. This story matters because health crises—like pandemics or drug-resistant infections—don’t care about nationality. Cutting off access to experts or data could leave everyone more vulnerable, including Americans. It’s a reminder that public health thrives on open exchange, not walls.